Stocks and Finance

Savient Pharmaceuticals

Savient Pharmaceuticals 5/8/2012

11:46 : Savient Pharmaceuticals ([[SVNT]] +18%) gets a pop after entering into ... - Savient Pharmaceuticals (SVNT +18%) gets a pop after entering into secured arrangements with some of its creditors to restructure its debt load and head off recent criticisms of its financial position. The stock has been ...
Source : seekingalpha-com

Savient Pharmaceuticals 3/1/2012

15:47 : William Blair initiates coverage on Savient Pharmaceuticals (SVNT) and ... - William Blair initiates coverage on Savient Pharmaceuticals (SVNT) and Ardea Biosciences (RDEA), citing their roles in developing therapies for gout. The firm estimates the U.S. gout market at $2B-$3B; ...
Source : seekingalpha-com

Savient Pharmaceuticals 9/19/2011

12:59 : Shares of Savient Pharmaceuticals ([[SVNT]] +7.5%) continue to climb after - Shares of Savient Pharmaceuticals (SVNT +7.5%) continue to climb after SEC filings show several key executives (I, II, III, IV) , including CEO John Johnson, purchased stock in the ...
Source : seekingalpha-com

Savient Pharmaceuticals 8/17/2011

13:32 : Savient Pharmaceuticals ([[SVNT]] -0.5%) gives back earlier gains after ... - Savient Pharmaceuticals (SVNT -0.5%) gives back earlier gains after the results from two Phase III studies of its drug Krystexxa showed significant reductions in uric acid levels among a substantial number of patients with ...
Source : seekingalpha-com

Savient Pharmaceuticals 8/4/2011

10:35 : Savient Pharmaceuticals ([[SVNT]] -25%) gets hammered after its Q2 results - Savient Pharmaceuticals (SVNT -25%) gets hammered after its Q2 results widely missed analysts' projections, as higher R&D, marketing and administrative expenses weighed on margins. Revenues were also down due to disappointing ...
Source : seekingalpha-com
actualidad Savient Pharmaceuticals -


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts